Pneumococcal vaccination of children after hematopoietic stem cell transplantation: Timing is crucial [2]

Clinical Infectious Diseases

Volumn 45, Issue 3, 2007, Pages 397-398

  Meisel, Roland ^a   Dilloo, Dagmar ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; IMMUNOSUPPRESSIVE AGENT; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; TETANUS TOXOID;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBODY RESPONSE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CHILD CARE; CLINICAL TRIAL; DRUG SAFETY; HLA SYSTEM; HUMAN; LETTER; PRIORITY JOURNAL; REVACCINATION; STREPTOCOCCUS INFECTION; TREATMENT INDICATION; UNITED KINGDOM;

BACTERIAL VACCINES; CHILD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; PNEUMOCOCCAL INFECTIONS; TIME FACTORS; VACCINATION;

EID: 34547105042     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/519508     Document Type: Letter

References (3)

1. Patel SR, Ortin M, Cohen BJ, et al. Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation. Clin Infect Dis 2007; 44:625-34.
2. Chisholm JC. Reimmunization after therapy for childhood cancer. Clin Infect Dis 2007; 44: 643-5.
3. Meisel R, Kuypers L, Dirksen U, et al. Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantation. Blood 2007; 109: 2322-6.